HAMILTON, ON, March 21, 2023 /PRNewswire/ — AtomVie Global Radiopharma Inc. (AtomVie) is pleased to announce that it has been selected among the presenting companies and will be available for 1-on-1 meetings at the following key investor conferences:
Jefferies Radiopharma Innovation Summit
Bloom Burton Healthcare Investor Conference
About AtomVie Global Radiopharma Inc. (AtomVie):
AtomVie, officially launched in August 2022 with the successful closing of its $40 million Series A financing from Avego. AtomVie, a spin-out of the Center for Probe Development and Commercialization (CPDC), is a world leading CDMO for GMP manufacturing and global distribution of clinical and commercial radiopharmaceuticals. Building on experience developed at CPDC, a McMaster University Center of Excellence, and its reputation as a high-quality radiopharmaceutical CDMO, AtomVie offers the full range of combined scientific, technical, regulatory, quality, logistics, and commercial expertise. with a specialized infrastructure for the development of radiopharmaceuticals from clinical studies to the commercial market. AtomVie currently serves 10 international clients conducting studies in more than 17 countries around the world. For more information about AtomVie, please visit www.atomvie.com or contact: info@atomvie.com.
About the Bloom Burton Healthcare Investor Conference
The Bloom Burton Healthcare Investor Conference
About Bloom Burton
Bloom Burton
Photo – https://mma.prnewswire.com/media/2036333…
info@atomvie.com
View original content: https://www.prnewswire.com/news-releases/atomvie-global-radiopharma-inc-presenta-en-conferencias-de-inversores-clave-301777236.html
